Real-world data sheds light on HPV throat cancer treatments
NCT ID NCT06771674
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 16 times
Summary
This study looked at 662 patients with HPV-positive throat cancer that had spread or come back. Researchers collected information on who these patients are, what treatments they received (pembrolizumab or nivolumab, with or without chemotherapy), and how well those treatments worked. The goal was to gather real-world data that can be compared with results from future clinical trials to better understand treatment benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OROPHARYNGEAL SQUAMOUS CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cardinal Health
Dublin, Ohio, 43017, United States
Conditions
Explore the condition pages connected to this study.